Viking Therapeutics Stock Forecast

Stock Price Forecast

The 10 analysts with 12-month price forecasts for Viking Therapeutics stock have an average target of 88, with a low estimate of 30 and a high estimate of 125. The average target predicts an increase of 166.83% from the current stock price of 32.98.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$30	$88	$102	$125
Change	-9.04%	+166.83%	+209.28%	+279.02%

* Price targets were last updated on Nov 12, 2025.

Analyst Ratings

The average analyst rating for Viking Therapeutics stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	7	7	7	7	7	5
Buy	5	5	5	5	5	3
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	14	14	14	14	14	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $106 → $107	Strong Buy	Maintains	$106 → $107	+224.44%	Nov 12, 2025
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy Initiates $106	Strong Buy	Initiates	$106	+221.41%	Oct 29, 2025
Hardik Parikh JP Morgan	JP Morgan	Buy Maintains $80 → $75	Buy	Maintains	$80 → $75	+127.41%	Oct 24, 2025
Michael Ulz Morgan Stanley	Morgan Stanley	Buy Maintains $98 → $102	Buy	Maintains	$98 → $102	+209.28%	Oct 23, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $102	Strong Buy	Reiterates	$102	+209.28%	Sep 29, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-4.47

from -3.19

EPS Next Year

-4.80

from -4.47

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-0.71	-0.90	-0.91	-1.01	-3.19	-4.47	-4.80
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	20	18

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-2.89	-3.03
Avg	-4.47	-4.80
Low	-7.27	-8.34

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.